GPCR Consortium Locks In First Corporate Partners
This article was originally published in PharmAsia News
A new multinational industry-academia consortium set up to elucidate the structures of G protein-coupled receptors (GPCRs) has confirmed its first corporate partners, with one Japanese pharma firm and two research institutes in Shanghai among the founder members of the initiative.
You may also be interested in...
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
Join us for a brief audio roundup of the major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Japanese major builds presence in novel device technology beyond its conventional therapeutics as looks towards a more holistic future of care.